Inventor
KWONG PETER
US44 patents
⚠️ This page may combine multiple inventors who share the name “KWONG PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
36 patentsUS9738689B2Aug 22, 2017
Prefusion RSV F proteins and their use
US HEALTH19 citations92
US10420834B2Sep 24, 2019
Recombinant metapneumovirus F proteins and their use
US HEALTH4 citations84
US10961283B2Mar 30, 2021
Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens
US HEALTH11 citations83
US10400015B2Sep 3, 2019
Recombinant HIV-1 envelope proteins and their use
US HEALTH10 citations82
US9475862B2Oct 25, 2016
Neutralizing GP41 antibodies and their use
US HEALTH6 citations82
US10562960B2Feb 18, 2020
Neutralizing antibodies to gp120 and their use
US HEALTH5 citations81
US11760790B2Sep 19, 2023
Neutralizing antibodies to HIV-1 Env and their use
US HEALTH2 citations72
US11602559B2Mar 14, 2023
HIV-1 Env fusion peptide immunogens and their use
US HEALTH2 citations72
US11078239B2Aug 3, 2021
Prefusion PIV F immunogens and their use
US HEALTH1 citations72
US10035845B2Jul 31, 2018
Neutralizing antibodies to HIV-1 and their use
US HEALTH2 citations72
US9738703B2Aug 22, 2017
Neutralizing antibodies to HIV-1 and their use
US HEALTH2 citations72
US12202886B2Jan 21, 2025
Neutralizing antibodies to GP120 and their use
US HEALTH1 citations71
US11939356B2Mar 26, 2024
Self-assembling insect ferritin nanoparticles
US HEALTH2 citations71
US11878998B2Jan 23, 2024
Prefusion RSV F proteins and their use
US HEALTH2 citations71
US11459360B2Oct 4, 2022
Recombinant HIV-1 envelope proteins and their use
US HEALTH4 citations71
US11174292B2Nov 16, 2021
Substitutions-modified prefusion RSV F proteins and their use
US HEALTH2 citations71
US11591372B2Feb 28, 2023
Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof
US HEALTH2 citations70
US10654898B2May 19, 2020
Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F protein and uses thereof
US HEALTH1 citations70
US12458691B2Nov 4, 2025
HIV-1 ENV fusion peptide immunogens and their use
US HEALTH0 citations62
US12435113B2Oct 7, 2025
Prefusion PIV F immunogens and their use
US HEALTH0 citations62
US12233124B2Feb 25, 2025
Recombinant metapneumovirus f proteins and their use
US HEALTH0 citations62
US11845778B2Dec 19, 2023
Prefusion PIV F immunogens and their use
US HEALTH0 citations62
US11786591B2Oct 17, 2023
Recombinant metapneumovirus F proteins and their use
US HEALTH0 citations62
US11027007B2Jun 8, 2021
Recombinant metapneumovirus F proteins and their use
US HEALTH0 citations62
US12145968B2Nov 19, 2024
Recombinant HIV-1 envelope proteins and their use
US HEALTH0 citations61
US11136356B2Oct 5, 2021
Recombinant HIV-1 envelope proteins and their use
US HEALTH0 citations61
US12275758B2Apr 15, 2025
Prefusion RSV F proteins and their use
US HEALTH0 citations60
US12545719B2Feb 10, 2026
Neutralizing antibodies to GP120 and their use
US HEALTH0 citations59
US12053519B2Aug 6, 2024
HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use
US HEALTH0 citations59
US12018051B2Jun 25, 2024
Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f protein and uses thereof
US HEALTH0 citations59
US12043660B2Jul 23, 2024
10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use
US HEALTH0 citations56
US11236152B2Feb 1, 2022
Neutralizing antibodies to HIV-1 GP41 and their use
US HEALTH0 citations56
US10858400B2Dec 8, 2020
Prefusion RSV F proteins and their use
US HEALTH0 citations51
US10047148B2Aug 14, 2018
Neutralizing GP41 antibodies and their use
US HEALTH0 citations50
US9783595B2Oct 10, 2017
Neutralizing GP41 antibodies and their use
US HEALTH0 citations50
US8044185B2Oct 25, 2011
Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes
US HEALTH0 citations48